Thank you for sharing!

Your article was successfully shared with the contacts you provided.

SAN DIEGO-Biotech firm eBioscience Corp. has signed a long-term lease to occupy the entire 49,347-square-foot, two-story 10240 Science Center Dr. office building in the Torrey Pines submarket. The company is expanding its corporate and administrative offices from its existing location across the street at 10255 Science Center Dr., where it will retain its lab facilities.

According to Todd R. Nelson, CEO of eBioscience, the company will be able to provide “more productive working environments” for both its administrative functions and its research and development lab facilities by having the two types of activities across the street from one another. The building that eBioscience will occupy was constructed in 2001 and is located off Science Center Drive, just west of Interstate 5 on a 2.75-acre site.

The building was purchased in May 2008 by Trammell Crow Co.’s Acquisition Funds team. purchased the building in May 2008. Tom Bak, senior managing director of Trammell Crow Co.’s Southern California Development and Investment Group in Irvine, notes that 10240 Science Center Dr. “was one of the few large blocks of space remaining in what has become San Diego’s premier pharmaceutical and biotech hub.” Bak adds that the flexible design of the building will enable eBioscience to customize its space to best fit its needs.

SVP Harry Lake III and principal Matt Hill with Trammell Crow Co. Acquisiton Funds team originated the investment for the fund and represented TCC in the transaction along with Bak and SVP Matt Cramer with Trammell Crow Co., along with SVP Jerry Keeney and senior associate Matt Nickels of the San Diego office of CB Richard Ellis. Additionally Keeney represented Alexandria Real Estate Equities and Trammell Crow Co. in the sale of 10240 Science Center Dr. in 2008.

Senior director Mickey Morera and associate director James Duncan of Cushman & Wakefield’s San Diego office represented eBioscience in the transaction. Trammell Crow Co. is an independently operated subsidiary of CB Richard Ellis Group.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.